Articles with public access mandates - Maria Stamelou (Μαρία Σταμέλου)Learn more
Not available anywhere: 23
Review
AFQ056 treatment of levodopa‐induced dyskinesias: results of 2 randomized controlled trials
D Berg, J Godau, C Trenkwalder, K Eggert, II Csoti, A Storch, H Huber, ...
Movement Disorders 26 (7), 1243-1250, 2011
Mandates: German Research Foundation
Review
Short‐term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo‐controlled trial
M Stamelou, A Reuss, U Pilatus, J Magerkurth, P Niklowitz, KM Eggert, ...
Movement disorders: official journal of the Movement Disorder Society 23 (7 …, 2008
Mandates: German Research Foundation
Review
Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification
HJ Huppertz, L Möller, M Südmeyer, R Hilker, E Hattingen, K Egger, ...
Movement Disorders 31 (10), 1506-1517, 2016
Mandates: German Research Foundation
Review
“Atypical” atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—a …
M Stamelou, NP Quinn, KP Bhatia
Movement Disorders 28 (9), 1184-1199, 2013
Mandates: UK Medical Research Council, Parkinson's UK
Review
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
H Wilson, G Dervenoulas, G Pagano, C Koros, T Yousaf, M Picillo, ...
The Lancet Neurology 18 (8), 748-759, 2019
Mandates: Alzheimers's UK, UK Medical Research Council, National Institute for Health …
Review
In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS
S Knake, M Belke, K Menzler, U Pilatus, KM Eggert, WH Oertel, ...
Movement Disorders 25 (9), 1232-1238, 2010
Mandates: German Research Foundation
Review
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
M Stamelou, G Respondek, N Giagkou, JL Whitwell, GG Kovacs, ...
Nature Reviews Neurology 17 (10), 601-620, 2021
Mandates: US National Institutes of Health, German Research Foundation, Volkswagen …
Review
Motor and nonmotor features of carriers of the p. A53T alpha‐synuclein mutation: a longitudinal study
D Papadimitriou, R Antonelou, M Miligkos, M Maniati, N Papagiannakis, ...
Movement Disorders 31 (8), 1226-1230, 2016
Mandates: US National Institutes of Health
Review
The role of cerebellum in patients with late onset cervical/segmental dystonia?–evidence from the clinic
A Batla, MC Sánchez, R Erro, C Ganos, M Stamelou, B Balint, F Brugger, ...
Parkinsonism & related disorders 21 (11), 1317-1322, 2015
Mandates: German Research Foundation, European Commission
Review
H‐ABC syndrome and DYT4: variable expressivity or pleiotropy of TUBB4 mutations?
R Erro, J Hersheson, C Ganos, NE Mencacci, M Stamelou, A Batla, ...
Movement Disorders 30 (6), 828-833, 2015
Mandates: German Research Foundation, UK Medical Research Council, Parkinson's UK …
Review
Atypical parkinsonism: diagnosis and treatment
M Stamelou, KP Bhatia
Neurologic clinics 33 (1), 39-56, 2015
Mandates: UK Medical Research Council, Parkinson's UK, Wellcome Trust
Review
The distinct movement disorder in anti‐NMDA receptor encephalitis may be related to status dissociatus: a hypothesis
M Stamelou, G Plazzi, E Lugaresi, MJ Edwards, KP Bhatia
Movement Disorders 27 (11), 1360-1363, 2012
Mandates: Parkinson's UK
Review
The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias
M Stamelou, J Diehl-Schmid, A Hapfelmeier, D Kontaxopoulou, L Stefanis, ...
Parkinsonism & related disorders 21 (10), 1264-1268, 2015
Mandates: German Research Foundation
Review
Patients with idiopathic rapid‐eye‐movement sleep behavior disorder show normal gastric motility assessed by the 13C‐octanoate breath test
MM Unger, JC Möller, K Mankel, K Schmittinger, KM Eggert, M Stamelou, ...
Movement disorders 26 (14), 2559-2563, 2011
Mandates: US National Institutes of Health
Review
One decade ago, one decade ahead in progressive supranuclear palsy
M Stamelou, N Giagkou, GU Höglinger
Movement Disorders 34 (9), 1284-1293, 2019
Mandates: German Research Foundation, Federal Ministry of Education and Research …
Review
Plasma glutathione and prodromal Parkinson's disease probability
S Charisis, E Ntanasi, M Stamelou, G Xiromerisiou, M Maraki, ...
Movement Disorders 37 (1), 200-205, 2022
Mandates: Government of Italy
Review
Characteristic constant groaning in late stage progressive supranuclear palsy: a case report
M Stamelou, I Rubio-Agusti, N Quinn, K Bhatia
Parkinsonism & Related Disorders 17 (7), 575-576, 2011
Mandates: Parkinson's UK
Review
TMEM230: How does it fit in the etiology and pathogenesis of Parkinson's disease?
W Mandemakers, M Quadri, M Stamelou, V Bonifati
Movement Disorders 32 (8), 1159-1162, 2017
Mandates: European Commission, Netherlands Organisation for Health Research and …
Review
DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study
C Koros, AM Simitsi, A Prentakis, N Papagiannakis, A Bougea, I Pachi, ...
Parkinsonism & Related Disorders 77, 36-42, 2020
Mandates: Michael J Fox Foundation
Review
Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes
M Stamelou, H Christ, A Reuss, W Oertel, G Höglinger
Movement Disorders 26 (5), 901-905, 2011
Mandates: US National Institutes of Health, German Research Foundation
Publication and funding information is determined automatically by a computer program